Abbott OTCs divested
This article was originally published in The Tan Sheet
Executive Summary
Ross Products parent records $30 mil. in Q4 from sale of Clear eyes eye drops, Murine eye drops and ear care products to Prestige Brands International. Deal was completed Dec. 30, according to Abbott, which says divested brands were profitable but no longer fit its strategic direction. Abbott expressed similar rationale for selling Selsun Blue dandruff shampoo line to Chattem last year (1"The Tan Sheet" March 11, 2002, p. 5). Sales for Ross division, which markets Similac infant formula and Ensure, Glucerna adult nutritionals, rose 3.4% in Q4 to $502 mil. but were flat for the year at $2.09 bil. During Jan. 16 analysts call, Abbott Medical Products Group President & COO Richard Gonzalez announces two "strategic introductions" for adult nutritionals segment in 2003 - Ensure in a plastic, reclosable container, and retail launch of Prosure, a product for weight loss in oncology patients that is currently available in the institutional segment...
You may also be interested in...
Abbott Q1 sales
Abbott Park, Ill.-based firm's Ross Products division's Q1 sales rose 3.8% to $604 mil., despite absence of revenue from Clear eyes eye drops, Murine eye and ear care products, which were divested to Prestige Brands International last quarter (1"The Tan Sheet" Jan. 20, 2003, In Brief). Sales increase likely was due to Ross' introduction of infant formulas fortified with docosahexaenoic acid and arachidonic acid...
Chattem Selsun Blue Purchase Provides Entry Into Five New Foreign Markets
Line extensions and a major marketing push are among the growth tactics Chattem expects to pursue when it brings Selsun Blue into its consumer health portfolio. Chattem has agreed to purchase the anti-dandruff line from Abbott Labs subsidiary Ross Products
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.